FR2517302B1 - - Google Patents

Info

Publication number
FR2517302B1
FR2517302B1 FR8218434A FR8218434A FR2517302B1 FR 2517302 B1 FR2517302 B1 FR 2517302B1 FR 8218434 A FR8218434 A FR 8218434A FR 8218434 A FR8218434 A FR 8218434A FR 2517302 B1 FR2517302 B1 FR 2517302B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8218434A
Other versions
FR2517302A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of FR2517302A1 publication Critical patent/FR2517302A1/fr
Application granted granted Critical
Publication of FR2517302B1 publication Critical patent/FR2517302B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0041—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR8218434A 1981-11-27 1982-11-03 Esters et amides de 13 14-bisdehydroprostaglandines Granted FR2517302A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8135799 1981-11-27

Publications (2)

Publication Number Publication Date
FR2517302A1 FR2517302A1 (fr) 1983-06-03
FR2517302B1 true FR2517302B1 (fr) 1984-12-14

Family

ID=10526190

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8218434A Granted FR2517302A1 (fr) 1981-11-27 1982-11-03 Esters et amides de 13 14-bisdehydroprostaglandines

Country Status (19)

Country Link
US (1) US4543353A (fr)
JP (1) JPS58103356A (fr)
AT (1) AT392964B (fr)
AU (1) AU552847B2 (fr)
BE (1) BE895137A (fr)
CA (1) CA1237718A (fr)
CH (1) CH656877A5 (fr)
DE (1) DE3241399A1 (fr)
DK (1) DK528982A (fr)
FI (1) FI77442C (fr)
FR (1) FR2517302A1 (fr)
GB (1) GB2111986B (fr)
IE (1) IE54347B1 (fr)
IL (1) IL67103A (fr)
IT (1) IT1153080B (fr)
NL (1) NL8204611A (fr)
SE (1) SE454588B (fr)
SU (2) SU1301309A3 (fr)
ZA (1) ZA827825B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2130575B (en) * 1982-11-09 1985-12-11 Erba Farmitalia Amide derivatives of 13, 14-didehydro-cycloalkyl-prostaglandins
GB8329559D0 (en) * 1983-11-04 1983-12-07 Erba Farmitalia Furyl derivatives of 16-substituted prostaglandins preparations
US4877871A (en) * 1988-06-14 1989-10-31 Nabisco Brands, Inc. Synthesis of sucrose polyester
US5972991A (en) * 1992-09-21 1999-10-26 Allergan Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
EP1159266B1 (fr) 1999-03-05 2004-11-03 Duke University Analogues de prostaglandines c-16 fp selectives insaturees
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US7351404B2 (en) 2002-02-04 2008-04-01 Allergan, Inc. Method of enhancing hair growth
US9216183B2 (en) 2002-02-04 2015-12-22 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US8758733B2 (en) 2002-02-04 2014-06-24 Allergan, Inc. Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
US9241918B2 (en) 2005-03-16 2016-01-26 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US7851504B2 (en) 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) * 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
EP2084124B9 (fr) * 2006-10-02 2015-07-01 Techfields Biochem Co. Ltd Promédicaments hydrosolubles de prostaglandines et composés analogues, positivement chargés, à taux de pénétration cutanée très élevé
US7507817B2 (en) * 2006-11-17 2009-03-24 Allergan, Inc. Prostaglandin prodrugs
KR101853971B1 (ko) 2007-06-04 2018-05-02 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
US7964595B2 (en) * 2008-01-18 2011-06-21 Allergan, Inc. Thiophenyl prostaglandin derivatives for treating glaucoma and ocular hypertension
CA2723894A1 (fr) * 2008-05-09 2009-11-12 Allergan, Inc. Derives therapeutiques substitues de l'hydantoine, et composes associes
EP2285796A1 (fr) * 2008-05-09 2011-02-23 Allergan, Inc. Thiazolidinones, oxazolidinones thérapeutiques substitués, et composés associés
US8722739B2 (en) * 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20100204335A1 (en) * 2008-12-01 2010-08-12 Allergan, Inc. Kit and composition for eyelash growth
CA2745206C (fr) 2008-12-04 2018-09-18 Chongxi Yu Compositions a penetration elevee et leurs applications
US9149484B2 (en) 2009-11-09 2015-10-06 Allergan, Inc. Compositions and methods for stimulating hair growth
US20110124736A1 (en) 2009-11-09 2011-05-26 Allergan, Inc. Compositions and methods for stimulating hair growth
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US8859616B2 (en) 2011-01-21 2014-10-14 Allergan, Inc. Compounds and methods for enhancing hair growth
JP5925158B2 (ja) * 2013-06-04 2016-05-25 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6030168B2 (ja) * 2015-03-09 2016-11-24 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ
JP6306067B2 (ja) * 2016-01-08 2018-04-04 テックフィールズ バイオケム カンパニー リミテッド 非常に高い皮膚浸透率を有するプロスタグランジン及び関連化合物の正荷電水溶性プロドラッグ

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE445717C (de) * 1924-05-16 1927-06-17 Chr Jonathan Sternkopf Vorrichtung zum Herstellen von Holzschliff fuer die Papier- u. dgl. Fabrikation
GB1425962A (en) * 1972-04-13 1976-02-25 Erba Carlo Spa Lactols and lactones
IT1053781B (it) * 1974-09-25 1981-10-10 Erba C S P A Ora Farmitalia Omega nor cicloalcil 13.14 deidro prostaglandine
IL51877A (en) * 1976-06-01 1981-09-13 Carlo Erba Sa -nor-16-benzyl or phenoxy-13,14-dehydro-prostaglandins and process for their preparation
FI71138C (fi) * 1976-12-31 1986-11-24 Erba Farmitalia Foerfarande foer framstaellning av terapeutiskt aktiva bisykliska prostaglandiner
IT1088966B (it) * 1977-11-15 1985-06-10 Erba Carlo Spa 13,14-dideidro-prostaglandine
SE446993B (sv) * 1980-07-09 1986-10-20 Mo Och Domsjoe Ab Forfarande for framstellning av blekt slipmassa
SE434069B (sv) * 1980-07-09 1984-07-02 Mo Och Domsjoe Ab Forfarande for framstellning av slipmassa

Also Published As

Publication number Publication date
IT8224327A0 (it) 1982-11-19
IL67103A0 (en) 1983-02-23
ATA421482A (de) 1990-12-15
DE3241399A1 (de) 1983-06-01
DK528982A (da) 1983-05-28
DE3241399C2 (fr) 1990-10-31
AT392964B (de) 1991-07-25
US4543353A (en) 1985-09-24
BE895137A (fr) 1983-05-25
JPS58103356A (ja) 1983-06-20
GB2111986A (en) 1983-07-13
ZA827825B (en) 1983-08-31
IL67103A (en) 1986-11-30
SU1301309A3 (ru) 1987-03-30
FI77442C (fi) 1989-03-10
GB2111986B (en) 1985-05-15
SU1321372A3 (ru) 1987-06-30
JPH0369899B2 (fr) 1991-11-05
IE54347B1 (en) 1989-08-30
SE8206731L (sv) 1983-05-28
IT1153080B (it) 1987-01-14
CH656877A5 (de) 1986-07-31
NL8204611A (nl) 1983-06-16
IE822568L (en) 1983-05-27
AU8979782A (en) 1983-06-02
FR2517302A1 (fr) 1983-06-03
AU552847B2 (en) 1986-06-26
FI824017L (fi) 1983-05-28
FI77442B (fi) 1988-11-30
FI824017A0 (fi) 1982-11-23
SE454588B (sv) 1988-05-16
IT8224327A1 (it) 1984-05-19
SE8206731D0 (sv) 1982-11-25
CA1237718A (fr) 1988-06-07

Similar Documents

Publication Publication Date Title
FR2499671B1 (fr)
FR2498484B1 (fr)
FR2497634B1 (fr)
FR2499182B1 (fr)
FR2498389B1 (fr)
DE3131996C2 (fr)
DE3205080C2 (fr)
DE3278440T1 (fr)
DE3102142C2 (fr)
DE3128206C2 (fr)
DE3208697C2 (fr)
FR2498264B1 (fr)
DE3107461C2 (fr)
DE3136204C2 (fr)
DE3113515C2 (fr)
DE3103016C2 (fr)
CH655687B (fr)
FR2498718B3 (fr)
FR2499341B1 (fr)
FR2498822B1 (fr)
DE3221949C2 (fr)
FR2499126B1 (fr)
FR2498149B1 (fr)
FR2498047B1 (fr)
CH655610B (fr)

Legal Events

Date Code Title Description
ST Notification of lapse